Literature DB >> 24603856

Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response.

K A Barksdale1, A C Lahti1, Rosalinda C Roberts1.   

Abstract

The anterior cingulate cortex (ACC) is one of several brain regions that are abnormal in schizophrenia (SZ). Here we compared markers of synapse and mitochondrial function using western blots of postmortem ACC in: 1) normal controls (NCs, n=13) vs subjects with SZ (n=25); NC, treatment-resistant SZ, and treatment-responsive SZ; and 3) NC and SZ treated with typical or atypical antipsychotic drugs (APDs). Protein levels of synaptophysin, mitofusin-2, vGLUT1, and calcineurin did not differ between the NC and SZ group as a whole, or the NCs vs the SZ group divided by treatment response or type of APDs. In several cases, the levels of vGLUT1 were minuscule or absent. The proportion of NCs lacking vGLUT1 was significantly less than that of the SZ groups. There were several positive correlations across all subjects between: 1) synaptophysin and vGLUT1; 2) synaptophysin and calcineurin; 3) synaptophysin and mitofusin; and 4) calcineurin and mitofusin. Synaptophysin and calcineurin were positively correlated in responders, and this correlation was significantly stronger than that in treatment-resistant SZ subjects or in NCs. Synaptophysin and calcineurin were positively correlated in SZ patients on atypical APDs; this correlation was significantly stronger than that in SZ patients on typical APDs or in NCs. Mitofusin-2 and calcineurin were positively correlated in SZ patients on atypical APDs and in NCs; this correlation was stronger in SZ patients on atypical rather than typical APDs or in NCs. The correlation between these proteins, which have roles in synaptic vesicle cycling, glutamate transmission, mitochondrial fusion, and calcium buffering, is complex and was differentially regulated among the groups.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603856      PMCID: PMC4104326          DOI: 10.1038/npp.2014.57

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  49 in total

1.  Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics.

Authors:  W J Rushlow; Y H Seah; D J Belliveau; N Rajakumar
Journal:  J Neurochem       Date:  2005-08       Impact factor: 5.372

2.  Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum.

Authors:  W G Staal; H E Hulshoff Pol; H G Schnack; N E van Haren; N Seifert; R S Kahn
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 3.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

4.  Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.

Authors:  S L Eastwood; P J Harrison
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

5.  A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain.

Authors:  Mark S Todtenkopf; Stephen L Vincent; Francine M Benes
Journal:  Schizophr Res       Date:  2005-02-01       Impact factor: 4.939

6.  Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia.

Authors:  Alice Egerton; Stefan Brugger; Marie Raffin; Gareth J Barker; David J Lythgoe; Philip K McGuire; James M Stone
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

7.  Aberrant "default mode" functional connectivity in schizophrenia.

Authors:  Abigail G Garrity; Godfrey D Pearlson; Kristen McKiernan; Dan Lloyd; Kent A Kiehl; Vince D Calhoun
Journal:  Am J Psychiatry       Date:  2007-03       Impact factor: 18.112

Review 8.  Neural functions of calcineurin in synaptic plasticity and memory.

Authors:  Karsten Baumgärtel; Isabelle M Mansuy
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

9.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors:  Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

10.  Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

View more
  10 in total

Review 1.  Postmortem studies on mitochondria in schizophrenia.

Authors:  Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2017-02-09       Impact factor: 4.939

2.  Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.

Authors:  Allison S Brandt; Paul G Unschuld; Subechhya Pradhan; Issel Anne L Lim; Gregory Churchill; Ashley D Harris; Jun Hua; Peter B Barker; Christopher A Ross; Peter C M van Zijl; Richard A E Edden; Russell L Margolis
Journal:  Schizophr Res       Date:  2016-02-28       Impact factor: 4.939

3.  Pathology of white matter integrity in three major white matter fasciculi: A post-mortem study of schizophrenia and treatment status.

Authors:  Kirsten E Schoonover; Charlene B Farmer; Andrew E Cash; Rosalinda C Roberts
Journal:  Br J Pharmacol       Date:  2019-03-18       Impact factor: 8.739

4.  Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.

Authors:  Lesley A McCollum; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2015-09-18       Impact factor: 4.939

5.  Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

Authors:  R C Roberts; K A Barksdale; J K Roche; A C Lahti
Journal:  Schizophr Res       Date:  2015-07-22       Impact factor: 4.939

6.  Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Authors:  Chijioke N Egbujo; Duncan Sinclair; Karin E Borgmann-Winter; Steven E Arnold; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2015-08-07       Impact factor: 4.939

7.  Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.

Authors:  Elias Mouchlianitis; Michael A P Bloomfield; Vincent Law; Katherine Beck; Sudhakar Selvaraj; Naresh Rasquinha; Adam Waldman; Federico E Turkheimer; Alice Egerton; James Stone; Oliver D Howes
Journal:  Schizophr Bull       Date:  2015-12-17       Impact factor: 9.306

8.  Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies.

Authors:  Rosalinda C Roberts
Journal:  Mitochondrion       Date:  2020-11-20       Impact factor: 4.160

9.  Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.

Authors:  Emanuele Felice Osimo; Katherine Beck; Tiago Reis Marques; Oliver D Howes
Journal:  Mol Psychiatry       Date:  2018-03-06       Impact factor: 15.992

10.  The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.

Authors:  Amira Bryll; Wirginia Krzyściak; Paulina Karcz; Natalia Śmierciak; Tamas Kozicz; Justyna Skrzypek; Marta Szwajca; Maciej Pilecki; Tadeusz J Popiela
Journal:  Biomolecules       Date:  2020-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.